Embolization Particle Market Trend, Share, Growth, Size and Forecast 2032

The global Embolization Particle market size accrued earnings worth approximately USD 1547.89 Million in 2023 and is predicted to gain revenue of about USD 3,918.02 Million by 2032, is set to record a CAGR of nearly 10.87% over the period from 2024 to 2032.

Request Free Sample

Embolization Particle market: Outlook

Embolization particles serve the purpose of halting bleeding or obstructing blood flow to tumors. Commonly utilized in the treatment of conditions such as liver cancer, renal cell carcinoma, kidney cancer, neuroendocrine tumors, arteriovenous malformation, uterine fibroids, and benign prostatic hyperplasia, these particles share similar appearances and handling characteristics. However, each embolic agent possesses distinct physical and chemical properties influencing its in vivo behavior. Clinicians must acquaint themselves with these differences to make informed choices regarding embolic agents and apply the appropriate embolization protocol. The sizes of embolization particles vary between 30 to 1200 µm based on the specific medical indication. This market includes drug-eluting beads, microspheres, Poly Vinyl Alcohol (PVA) Particles, and Radioembolization Particles.

The study includes drivers and restraints for the embolization particle market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the embolization particle market on a global level.

Embolization therapy is a minimally invasive treatment that obstructs the blood flow into one or more blood vessels feeding to the malformations, such as hypervascularized tumors and arteriovenous malformations. During the catheter embolization procedure, embolic material is injected into blood vessels to block the blood flow inside the tumor or malformation, which shrinks the malformations with time. The process of embolization treats Hepatocellular carcinoma (HCC), renal cell carcinoma (RCC), liver cancer tumors, kidney cancer tumors, etc. Embolization therapy is performed by interventional radiologists and offers many benefits as compared to conventional surgical treatments. These benefits include minimally invasive surgeries, are highly effective in controlling bleeding, reduce trauma, faster recovery time, minimal risk of infection, no scarring, etc.

In order to give the users of this report a comprehensive view of the embolization particle market, we have included a competitive landscape and an analysis of Porter’s Five Forces model of the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Request Free Sample

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

Embolization Particle Market: Segment Analysis

The study provides a decisive view of the embolization particle market by segmenting the market based on particle type, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. 

Based on particles type, the embolization particle market is segmented into microspheres, particles, drug-eluting beads (DEBs), and radio-embolic microspheres. Particles are expected to dominate the market in the upcoming years. 

Based on application, the embolization particle market is segmented into trauma embolization, liver tumor embolization, prostatic artery embolization, uterine fibroid embolization, and others. Trauma embolization is likely to grow rapidly in the estimated time period.

Embolization Particle Market: Report Scope

Embolization Particle Market: Regional Analysis

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further bifurcation into major countries, including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

North America is likely to dominate the embolization particle market in the upcoming years, owing to the presence of developed countries and advanced healthcare infrastructure. Europe is expected to closely follow North America in terms of revenue. The Asia Pacific region is projected to grow rapidly owing to the presence of developing economies, such as India and China. Latin American and the Middle Eastern and African regions are expected to grow moderately in the forecast time period.

Embolization Particle Market: Competitive Analysis

Some major players of the embolization particle market include

• Sirtex Medical Pty. Ltd.
• Guerbet
• Boston Scientific Corporation
• Medtronic
• Merit Medical Systems
• BTG International Ltd.
• KAVYA PHARMA
• Which Medical Device
• Varian Medical Systems Inc.
• Terumo Medical Corporation
• Cook and Interface BIOmaterials
• Among others

The global embolization particle market is segmented as follows:

Global Embolization Particle Market: Particle Type Analysis

• Microspheres
• Particles
• Drug-Eluting Beads (DEBs)
• Radio-Embolic Microspheres

Global Embolization Particle Market: Application Analysis

• Trauma Embolization
• Liver Tumor Embolization
• Prostatic Artery Embolization
• Uterine Fibroid Embolization
• Others

Global Embolization Particle Market: End User Analysis

• Hospitals

• Clinics
• Ambulatory Centers
• Others

Global Embolization Particle Market: Regional Segments

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa